検索結果 752 件
フルテキストURL | JoAmChemSoc_2017_139_12_4376.pdf |
---|---|
著者 | Niho, Akiko| Yoshizawa, Susumu| Tsukamoto, Takashi| Kurihara, Marie| Tahara, Shinya| Nakajima, Yu| Mizuno, Misao| Kuramochi, Hikaru| Tahara, Tahei| Mizutani, Yasuhisa| Sudo, Yuki| |
備考 | This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of the American Chemical Society, copyright © American Chemical Society after peer review and technical editing by the publisher.| |
発行日 | 2017-03-29 |
出版物タイトル | Journal of the American Chemical Society |
巻 | 139巻 |
号 | 12号 |
出版者 | American Chemical Society |
開始ページ | 4376 |
終了ページ | 4389 |
ISSN | 00027863 |
NCID | AA00692602 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
論文のバージョン | author |
PubMed ID | 28257611 |
DOI | 10.1021/jacs.6b12139 |
Web of Science KeyUT | 000398247100034 |
関連URL | isVersionOf https://doi.org/10.1021/jacs.6b12139 |
フルテキストURL | K0005475_abstract_review.pdf K0005475_summary.pdf K0005475_fulltext.pdf |
---|---|
著者 | 鍛治園 誠| |
発行日 | 2017-03-24 |
資料タイプ | 学位論文 |
学位授与番号 | 甲第5475号 |
学位授与年月日 | 2017-03-24 |
学位・専攻分野 | 博士(医学) |
授与大学 | 岡山大学 |
言語 | 英語 |
JaLCDOI | 10.18926/AMO/54988 |
---|---|
フルテキストURL | 71_2_181.pdf |
著者 | Hayata, Kei| Hiramatsu, Yuji| Masuyama, Hisashi| Eto, Eriko| Mitsui, Takashi| Tamada, Shoko| |
抄録 | We experienced a case of advanced maternal age in which a fetus was found to be positive for trisomy 18 at re-examination following indeterminate non-invasive prenatal genetic testing (NIPT), the amniotic fluid chromosomal test revealed a normal karyotype, and confined placental mosaicism (CPM) was observed in an SNP microarray analysis of the placenta. The child was born with no defects or complications. In the present case, the result of the original NIPT at week 15 of pregnancy was indeterminate and the subsequent re-examination result was positive; since the definitive normal diagnosis was not reported until the latter half of week 21, the pregnant patient was subjected to psychological stress for a long period of time. The problem with NIPT is that most of the fetus-derived cell-free DNA in the maternal blood is not derived directly from the fetus but from the villus cells of the placenta, leading to indefinite diagnoses; for that reason, the pregnant patient was subjected to psychological stress for a long period of time. Of the 18,251 cases undergoing NIPT in the past 2 years in Japan, 51 had indeterminate results; this was the second case in which a subsequent re-examination gave a positive result for trisomy 18. |
キーワード | non-invasive prenatal genetic testing massively parallel sequencing confined placental mosaicism genetic counseling trisomy 18 |
Amo Type | Case Report |
出版物タイトル | Acta Medica Okayama |
発行日 | 2017-04 |
巻 | 71巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 181 |
終了ページ | 185 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2017 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 28420901 |
JaLCDOI | 10.18926/AMO/54987 |
---|---|
フルテキストURL | 71_2_179.pdf |
著者 | Nosaka, Nobuyuki| Tsukahara, Kohei| Knaup, Emily| Yabuuchi, Toshihiko| Kikkawa, Tomonobu| Fujii, Yosuke| Yashiro, Masato| Yasuhara, Takao| Okada, Ayumi| Ugawa, Toyomu| Nakao, Atsunori| Tsukahara, Hirokazu| Date, Isao| |
抄録 | Newly published clinical practice guidelines recommend intracranial pressure (ICP) monitoring in critical care for the management of pediatric acute encephalopathy (pAE), but the utility of ICP monitoring for pAE has been poorly studied. We recently performed direct ICP monitoring for two patients. We observed that although the direct ICP monitoring had clinical benefits with less body weight gain and no vasopressor use in both cases, this monitoring technique is still invasive. Future studies should determine the utility of non-invasive ICP monitoring systems in pAE to further improve the quality of intensive-care management. |
キーワード | cerebral perfusion encephalopathy child intracranial pressure neurological intensive care |
Amo Type | Short Communication |
出版物タイトル | Acta Medica Okayama |
発行日 | 2017-04 |
巻 | 71巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 179 |
終了ページ | 180 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2017 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 28420900 |
JaLCDOI | 10.18926/AMO/54981 |
---|---|
フルテキストURL | 71_2_127.pdf |
著者 | Shirakawa, Yasuhiro| Noma, Kazuhiro| Maeda, Naoaki| Tanabe, Shunsuke| Kuroda, Shinji| Kagawa, Shunsuke| Katsui, Kuniaki| Katayama, Norihisa| Kanazawa, Susumu| Fujiwara, Toshiyoshi| |
抄録 | Currently, chemoradiation is the most widely used nonsurgical treatment for esophageal cancer. However, some patients, particularly the very elderly or those with severe vital organ dysfunction, face difficulty with the chemotherapy component. We therefore examined the outcome of radiation therapy (RT) alone for patients with esophageal cancer at our facility. Between January 2005 and December 2014, 84 patients underwent RT at our hospital, and 78 of these patients received concomitant chemotherapy. The remaining 6 patients underwent RT alone; these patients were considered to be high-risk and to have no lymph node metastasis (stage I). Five of them received irradiation up to a curative dose: 4 showed a complete response (CR) and 1 showed a partial response (PR). Of the patients exhibiting CR, 3 are currently living recurrence-free, whereas 1 patient underwent endoscopic submucosal dissection (ESD) as salvage therapy for local recurrence, with no subsequent recurrence. High-risk stage I esophageal cancer patients can be treated radically with RT alone under certain conditions. In the future, to broaden the indications for RT monotherapy to include some degree of advanced cancers, a novel concurrent therapy should be identified. |
キーワード | esophageal cancer radiation therapy high-risk patient |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2017-04 |
巻 | 71巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 127 |
終了ページ | 133 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2017 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 28420894 |
タイトル(別表記) | Does hydrogen-rich water really work? |
---|---|
フルテキストURL | 129_9.pdf |
著者 | 中尾 篤典| |
キーワード | 水素水 抗酸化作用 抗炎症作用 臨床応用 疑似科学 |
出版物タイトル | 岡山医学会雑誌 |
発行日 | 2017-04-03 |
巻 | 129巻 |
号 | 1号 |
開始ページ | 9 |
終了ページ | 15 |
ISSN | 0030-1558 |
言語 | 日本語 |
著作権者 | Copyright (c) 2017 岡山医学会 |
論文のバージョン | publisher |
DOI | 10.4044/joma.129.9 |
NAID | 130005632038 |
タイトル(別表記) | The 2015 Incentive Award of the Okayama Medical Association in Cancer Research (2015 Hayashibara Prize and Yamada Prize) |
---|---|
フルテキストURL | 129_5.pdf |
著者 | 磯崎 英子| |
出版物タイトル | 岡山医学会雑誌 |
発行日 | 2017-04-03 |
巻 | 129巻 |
号 | 1号 |
開始ページ | 5 |
終了ページ | 8 |
ISSN | 0030-1558 |
関連URL | isVersionOf https://doi.org/10.1158/0008-5472.CAN-15-1010 |
言語 | 日本語 |
著作権者 | Copyright (c) 2017 岡山医学会 |
論文のバージョン | publisher |
DOI | 10.4044/joma.129.5 |
NAID | 130005632073 |
著者 | 大仲 克俊| |
---|---|
発行日 | 2017-02-01 |
出版物タイトル | 岡山大学農学部学術報告 |
巻 | 106巻 |
資料タイプ | 紀要論文 |
著者 | Kim, Kwang-Seob| Kishi, Yasuhiro| |
---|---|
発行日 | 2017-01 |
出版物タイトル | Mathematical Journal of Okayama University |
巻 | 59巻 |
号 | 1号 |
資料タイプ | 学術雑誌論文 |
JaLCDOI | 10.18926/mjou/54717 |
著者 | 後藤田 達洋| 川野 誠司| 河野 吉泰| 三浦 公| 神崎 洋光| 岩室 雅也| 河原 祥朗| 田中 健大| 吉野 正| 白川 靖博| 田端 雅弘| 谷本 光音| 岡田 裕之| |
---|---|
発行日 | 2016-12-01 |
出版物タイトル | 岡山医学会雑誌 |
巻 | 128巻 |
号 | 3号 |
資料タイプ | 学術雑誌論文 |
JaLCDOI | 10.18926/AMO/54607 |
---|---|
フルテキストURL | 70_5_425.pdf |
著者 | Tamura, Tomoki| Hirata, Taizo| Tabata, Masahiro| Hinotsu, Shiro| Hamada, Akinobu| Motoki, Takayuki| Iwamoto, Takayuki| Mizoo, Taeko| Nogami, Tomohiro| Shien, Tadahiko| Taira, Naruto| Matsuoka, Junji| Doihara, Hiroyoshi| |
抄録 | Docetaxel is a standard treatment for patients with advanced or recurrent breast cancer. The recommended dose is 60 to 100 mg/m2. Previous study have shown that the tumor response rates of patients who received docetaxel monotherapy at doses of 60, 75, and 100 mg/m2 were 22.1% , 23.3% , and 36.0% , respectively, and there was a significant relationship between the dose and response. In Europe and the United States, docetaxel is approved at a dose of 100 mg/m2, and Japanese guidelines also recommend a dose of 100 mg/m2. However, the approved dose in Japan is up to 75 mg/m2. We have launched a phase I trial evaluating 100 mg/m2 docetaxel in patients with advanced or relapsed breast cancer. The major eligibility criteria are as follows: age ≥20 years, pathologically diagnosed breast cancer, recurrent or advanced breast cancer, a good performance status, and HER2 [human epidermal growth factor receptor 2] negative. The primary endpoint is demonstrated safety of 100 mg/m2 docetaxel. This study will clarify whether 100mg/m2 docetaxel can be administrated safely in Japanese patients with advanced or recurrent breast cancer. |
キーワード | breast cancer phase I trial docetaxel |
Amo Type | Clinical Study Protocols |
出版物タイトル | Acta Medica Okayama |
発行日 | 2016-10 |
巻 | 70巻 |
号 | 5号 |
出版者 | Okayama University Medical School |
開始ページ | 425 |
終了ページ | 427 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2016 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 27777441 |
Web of Science KeyUT | 000388098700018 |
JaLCDOI | 10.18926/AMO/54590 |
---|---|
フルテキストURL | 70_5_331.pdf |
著者 | Iida, Atsuyoshi| Nosaka, Nobuyuki| Yumoto, Tetsuya| Knaup, Emily| Naito, Hiromichi| Nishiyama, Chihiro| Yamakawa, Yasuaki| Tsukahara, Kohei| Terado, Michihisa| Sato, Keiji| Ugawa, Toyomu| Nakao, Atsunori| |
抄録 | In recent years, it has become evident that molecular hydrogen is a particularyl effective treatment for various disease models such as ischemia-reperfusion injury; as a result, research on hydrogen has progressed rapidly. Hydrogen has been shown to be effective not only through intake as a gas, but also as a liquid medication taken orally, intravenously, or locally. Hydrogenʼs effectiveness is thus multifaceted. Herein we review the recent research on hydrogen-rich water, and we examine the possibilities for its clinical application. Now that hydrogen is in the limelight as a gaseous signaling molecule due to its potential ability to inhibit oxidative stress signaling, new research developments are highly anticipated. |
キーワード | hydrogen antioxidant effect medical gas gaseous signaling molecule clinical tests |
Amo Type | Review |
出版物タイトル | Acta Medica Okayama |
発行日 | 2016-10 |
巻 | 70巻 |
号 | 5号 |
出版者 | Okayama University Medical School |
開始ページ | 331 |
終了ページ | 337 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2016 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 27777424 |
Web of Science KeyUT | 000388098700001 |
フルテキストURL | K0005389_abstract_review.pdf K0005389_fulltext.pdf |
---|---|
著者 | 出石 恭久| |
発行日 | 2016-06-30 |
資料タイプ | 学位論文 |
学位授与番号 | 甲第5389号 |
学位授与年月日 | 2016-06-30 |
学位・専攻分野 | 博士(医学) |
授与大学 | 岡山大学 |
言語 | 英語 |
著者 | Ohtsuki, Takashi| Miki, Shunya| Kobayashi, Shouhei| Haraguchi, Tokuko| Nakata, Eiji| Hirakawa, Kazutaka| Sumita, Kensuke| Watanabe, Kazunori| Okazaki, Shigetoshi| |
---|---|
発行日 | 2015-12 |
出版物タイトル | Scientific Reports |
巻 | 5巻 |
資料タイプ | 学術雑誌論文 |
JaLCDOI | 10.18926/AMO/54500 |
---|---|
フルテキストURL | 70_4_255.pdf |
著者 | Nosaka, Nobuyuki| Fujiwara, Takeo| Knaup, Emily| Okada, Ayumi| Tsukahara, Hirokazu| |
抄録 | Estimation methods for pediatric weight have not been evaluated for Japanese children. This study aimed to assess the accuracy of mothersʼ reports of their childrenʼs weight in Japan. We also evaluated potential alternatives to the estimation of weight, including the Broselow tape (BT), Advanced Pediatric Life Support (APLS), and Parkʼs formulae. We prospectively collected cross-sectional data on a convenience sample of 237 children aged less than 10 years who presented to a general pediatric outpatient clinic with their mothers. Each weight estimation method was evaluated using Bland-Altman plots and by calculating the proportion within 10 and 20 of the measured weight. Mothersʼ reports of weight were the most accurate method, with 94.9 within 10 of the measured weight, the lowest mean difference (0.27kg), and the shortest 95 limit of agreement (-1.4 to 1.9kg). The BT was the most reliable alternative, followed by APLS and Parkʼs formulae. Mothersʼ reports of their children ʼs weight are more accurate than other weight estimation methods. When no report of a childʼs weight by the mother is available, BT is the best alternative. When an aged-based formula is the only option, the APLS formula is preferred. |
キーワード | body weight child estimation techniques mothers, parents |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2016-08 |
巻 | 70巻 |
号 | 4号 |
出版者 | Okayama University Medical School |
開始ページ | 255 |
終了ページ | 259 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2016 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 27549669 |
Web of Science KeyUT | 000384748600004 |
著者 | 中谷 ひとみ| |
---|---|
発行日 | 2015-12-25 |
出版物タイトル | 岡山大学文学部紀要 |
巻 | 64巻 |
資料タイプ | 紀要論文 |
JaLCDOI | 10.18926/okadai-bun-kiyou/54447 |
JaLCDOI | 10.18926/AMO/54423 |
---|---|
フルテキストURL | 70_3_223.pdf |
著者 | Ebara, Shin| Kobayashi, Yasuyuki| Sasaki, Katsumi| Araki, Motoo| Sugimoto, Morito| Wada, Koichirou| Fujio, Kei| Takamoto, Atsushi| Watanabe, Toyohiko| Yanai, Hiroyuki| Nasu, Yasutomo| |
抄録 | The present case report describes a case of recurrent and advanced urachal carcinoma including neuroendocrine features with iliac bone metastasis after partial cystectomy and adjuvant chemotherapy consisting of irinotecan and cisplatin in a 32-year-old man. He received gemcitabine/cisplatin/ paclitaxel (GCP) combination chemotherapy, consisting of gemcitabin (1,000mg/m2) on day 1, 8, cisplatin (70mg/m2) on day 1, and paclitaxel (80mg/m2) on day 1 and 8. After three cycles of chemotherapy, PET-CT showed complete regression of the disease. So the patient underwent total cystourethrectomy, and histological examination showed an almost complete pathological response. External beam radiation therapy was also given to the ileac bone metastasis regions. However, PET-CT taken 17 months after the external beam radiation showed multiple lung metastases. He received GCP chemotherapy again, which resulted in a complete response again after three cycles of chemotherapy. This is the first report on GCP chemotherapy used not only as a salvage chemotherapy but also as a rechallenge regimen for metastatic urachal cancer including a neuroendocrine component. |
Amo Type | Case Report |
出版物タイトル | Acta Medica Okayama |
発行日 | 2016-06 |
巻 | 70巻 |
号 | 3号 |
出版者 | Okayama University Medical School |
開始ページ | 223 |
終了ページ | 227 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2016 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 27339213 |
Web of Science KeyUT | 000379406100011 |
JaLCDOI | 10.18926/AMO/54418 |
---|---|
フルテキストURL | 70_3_189.pdf |
著者 | Fujiwara, Hiroyasu| Arai, Yasuaki| Ishii, Hiroaki| Kanazawa, Susumu| |
抄録 | We retrospectively evaluated the safety and efficacy of artificial pneumothorax induction to perform computed tomography (CT)-guided radiofrequency ablation (RFA) for sub-diaphragm hepatocellular carcinomas (HCCs). From June 2008 to October 2010 at our institution, 19 HCCs (16 patients) were treated using CT-guided RFA after artificial pneumothorax induction. A 23-G needle was inserted into the liver surface at a site of 2 connected pleurae without lung tissue. After a small amount of air was injected, the pleural space widened, creating a small pneumothorax. Additional air was insufflated via a newly inserted 18-G cannula to raise the lung away from the planned puncture line for RFA. The electrode was then advanced transthoracically. Ablation was performed using a cool-tip electrode with manual impedance control mode. The injected air was then aspirated as much as possible. Artificial pneumothorax was successfully induced in all cases. The average total volume of injected air in each case was 238ml. No artificial pneumothorax-related complication occurred; lung injury occurred in one case during RF electrode insertion. No local progression occurred during follow-up. Recurring HCCs were observed in eight patients. Artificial pneumothorax induction is safe and effective for CT-guided RFA of sub-diaphragm HCCs, which are difficult to locate on US. |
キーワード | hepatocellular carcinoma liver radiofrequency ablation CT fluoroscopy artificial pneumothorax |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2016-06 |
巻 | 70巻 |
号 | 3号 |
出版者 | Okayama University Medical School |
開始ページ | 189 |
終了ページ | 195 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2016 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 27339208 |
Web of Science KeyUT | 000379406100006 |
著者 | 木村 透| |
---|---|
発行日 | 2016-04 |
出版物タイトル | 岡山実験動物研究会報 |
巻 | 32巻 |
資料タイプ | その他 |
著者 | 矢田 範夫| 上藤 千佳| 平山 晴子| 樅木 勝巳| |
---|---|
発行日 | 2016-04 |
出版物タイトル | 岡山実験動物研究会報 |
巻 | 32巻 |
資料タイプ | 学術雑誌論文 |